These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19237840)

  • 61. A high chromogranin A: Is it always a tumor?
    Turhan Iyidir O; Cimen AR; Değertekin CK; Baloş Törüner F; Cakır N; Arslan M
    Turk J Gastroenterol; 2013; 24(2):186-7. PubMed ID: 23934470
    [No Abstract]   [Full Text] [Related]  

  • 62. Association between pulmonary tuberculosis and acid suppressive agents.
    Lai SW; Lin CL; Liao KF
    Postgrad Med J; 2020 Mar; 96(1133):165. PubMed ID: 31511318
    [No Abstract]   [Full Text] [Related]  

  • 63. [Vitamin B12 deficiency and acid blockers - connection is there, causality remains unclear].
    Markun S
    Praxis (Bern 1994); 2014 Apr; 103(9):541-2. PubMed ID: 24755505
    [No Abstract]   [Full Text] [Related]  

  • 64. Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia.
    Gori G; Spinelli G; Spinelli C; Tuccori M; Blandizzi C; Del Tacca M
    Nat Rev Gastroenterol Hepatol; 2010 Nov; 7(11):642-6. PubMed ID: 20938461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Omeprazole for everybody?].
    Sánchez DP; Guillén JJ; Torres AM; Sánchez FI
    Aten Primaria; 2014; 46(6):315-6. PubMed ID: 24697916
    [No Abstract]   [Full Text] [Related]  

  • 66. Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors.
    Wang HS; Oh DS; Ohning GV; Pisegna JR
    J Mol Neurosci; 2007; 33(3):225-31. PubMed ID: 17952631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and the Risk of Kidney Stones: Negligible or Not?
    Pella E; Chalkidou M; Sarafidis P
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):624-625. PubMed ID: 33249019
    [No Abstract]   [Full Text] [Related]  

  • 68. Potential Biases in Studies of Acid-Suppressing Drugs and COVID-19 Infection.
    Etminan M; Nazemipour M; Candidate MS; Mansournia MA
    Gastroenterology; 2021 Apr; 160(5):1443-1446. PubMed ID: 33340538
    [No Abstract]   [Full Text] [Related]  

  • 69. Prolonged ulcerative laryngitis in an 18-year-old voice major.
    Toland BL; DeFatta RA; Sataloff RT
    Ear Nose Throat J; 2013; 92(4-5):E24. PubMed ID: 23599113
    [No Abstract]   [Full Text] [Related]  

  • 70. Chromogranin A is not a biomarker of mastocytosis.
    Hanjra P; Lee CR; Maric I; Carter M; Olivera A; Metcalfe DD; Komarow HD
    J Allergy Clin Immunol Pract; 2018; 6(2):687-689.e4. PubMed ID: 29033257
    [No Abstract]   [Full Text] [Related]  

  • 71. Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Waldum HL; Fossmark R
    Gut; 2018 Jan; 67(1):199-200. PubMed ID: 29158236
    [No Abstract]   [Full Text] [Related]  

  • 72. Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion.
    Waldum HL; Syversen U
    Eur J Clin Invest; 2001 Sep; 31(9):741-3. PubMed ID: 11589715
    [No Abstract]   [Full Text] [Related]  

  • 73. Proton-pump inhibitors in managed care.
    Frear RS
    Am J Health Syst Pharm; 1998 Nov; 55(21):2249. PubMed ID: 9825876
    [No Abstract]   [Full Text] [Related]  

  • 74. The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key?
    Sciorati C; De Lorenzo R; Lorè NI; Tresoldi C; Cirillo DM; Ciceri F; Corti A; Manfredi AA; Rovere-Querini P
    Pharmacol Res; 2023 Jan; 187():106601. PubMed ID: 36513209
    [No Abstract]   [Full Text] [Related]  

  • 75. Is proton pump inhibitor use a significant confounder for chromogranin A levels in sepsis?
    Haranath SP; Jakkinaboina S
    Intensive Care Med; 2012 Nov; 38(11):1901; author reply 1902-3. PubMed ID: 22893219
    [No Abstract]   [Full Text] [Related]  

  • 76. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Chang YW
    Korean J Gastroenterol; 2009 Feb; 53(2):126-8. PubMed ID: 19237840
    [No Abstract]   [Full Text] [Related]  

  • 77. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW
    Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists.
    Daure E; Ross L; Webster CR
    J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination therapy.
    Katz P
    Postgrad Med; 2000 May; 107(5 Suppl):31-3; discussion 33-4. PubMed ID: 19667512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.